KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $368.0 million.

  • Gilead Sciences' Other Working Capital Changes rose 54561.4% to $368.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $421.0 million, marking a year-over-year increase of 19034.48%. This contributed to the annual value of $259.0 million for FY2024, which is 76410.26% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Other Working Capital Changes is $368.0 million, which was up 54561.4% from -$81.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Other Working Capital Changes ranged from a high of $368.0 million in Q3 2025 and a low of -$81.0 million during Q2 2025
  • Its 5-year average for Other Working Capital Changes is $35.5 million, with a median of $19.0 million in 2024.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 124000.0% in 2024, then tumbled by 52631.58% in 2025.
  • Gilead Sciences' Other Working Capital Changes (Quarter) stood at $28.0 million in 2021, then surged by 132.14% to $65.0 million in 2022, then tumbled by 50.77% to $32.0 million in 2023, then surged by 356.25% to $146.0 million in 2024, then soared by 152.05% to $368.0 million in 2025.
  • Its last three reported values are $368.0 million in Q3 2025, -$81.0 million for Q2 2025, and -$12.0 million during Q1 2025.